Ranibizumab Intraocular and Rituximab and hyaluronidase human, recombinant Subcutaneous

• Generic Name: ranibizumab ophthalmic
• Dosage Forms: n.a.
• Other Brand Names: Lucentis

Ranibizumab is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurring of vision or blindness. Ranibizumab works by changing the amount of blood that gets to the eye.

Ranibizumab is also used to treat myopic choroidal neovascularization (mCNV).

Ranibizumab is used to treat macular edema (swelling of the back of the eye) after retinal vein occlusion (a blood vessel in the eye is blocked). It is also used in diabetic patients who have diabetic macular edema (DME). Macular edema can cause loss of vision. Ranibizumab is also used to treat diabetic retinopathy (eye problem caused by diabetes).

Ranibizumab is to be given only by or under the direct supervision of your doctor.

• Generic Name: hyaluronidase / rituximab
• Dosage Forms: n.a.
• Other Brand Names: Rituxan Hycela

Rituximab and hyaluronidase human, recombinant combination injection is used alone or together with other cancer medicines to treat follicular lymphoma and chronic lymphocytic leukemia (CLL). It is also used together with other medicines to treat diffuse large B-cell lymphoma (DLBCL) in people who have not received previous treatment.

Rituximab and hyaluronidase human, recombinant combination injection is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body.

Rituximab and hyaluronidase human, recombinant is to be given only by or under the direct supervision of your doctor.